Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration

Author(s):  Lopez C Vidal, Rios GL Quito

Issue:  Sep/Oct 2022 - Volume 26, Number 5
View All Articles in Issue

Page(s):  358-362

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Page 1
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Page 2
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Page 3
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Page 4
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Page 5

Download in electronic PDF format for $75

Abstract:  In 2016, the National Institute for Occupational Safety and Health (NIOSH) published a list of hazardous drugs in healthcare. The handling of such drugs must be conducted using closed system devices according to United States Pharmacopeia General Chapter <800> and other regulations, such as Directive (EU) 2022/431 of the European Parliament and of the Council of 9 March 2022 amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work. There are approximately 90 enterally administered drugs on the NIOSH list. In this list, NIOSH established that crushing tablets or making solutions from them causes an unacceptable risk at hospitals. Furthermore, United States Pharmacopeia <800> and European regulations impose the use of closed system devices and plastic pouches to contain any dust or particles generated during these operations. While there are several marketed closed system drug-transfer devices for intravenous treatments, there is no single system to crush, disperse, and administer hazardous drugs safely via enteral. This poses a great risk for patients who cannot swallow properly or are fed by an enteral tube. To solve this problem, we developed a new medical device to protect caregivers from such risks. We patented a new device that allows a safe administration and reduces exposure risk and environmental pollution at pharmacy departments (cross-contamination in cabinets), nursery units, and even at patients’ homes to protect caregivers and relatives. This initiative by a hospital pharmacist aims to solve a daily problem and provide an example of our potential in healthcare innovation.

Related Keywords: C. Vidal Lopez, BPharm, G. L. Rios Quito, MD, hazardous drugs, worker protection, heatlhcare worker safety, carcinogens, mutations, workplace exposure, closed system drug-transfer devices, dysphagia, enteral administration, United States Pharmacopeia Chapter <800>, USP, European Parliament Directive 2022/431, drug toxic effects

Related Categories: TECHNOLOGY, HOSPITAL PHARMACY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe
, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016
Pg. 148-154

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
Mar/Apr 2007
Pg. 149-151

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Compounding Using Hazardous Drugs
Lau Kellie
Jul/Aug 2000
Pg. 261-263

Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection
Allen Loyd V Jr
Jan/Feb 2007
Pg. 50-51

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2009
Pg. 56-62

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J
, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Sep/Oct 2012
Pg. 431-433

Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
Sep/Oct 2006
Pg. 377-379

Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
Jul/Aug 2009
Pg. 300-310

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Facilities and Procedures for Compounding Hazardous Drugs
Rahe Hank
Jul/Aug 2002
Pg. 267-270

Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina
, Baskett Dustin
Sep/Oct 2018
Pg. 387-398

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise
, Blackburn Paul L
Mar/Apr 2013
Pg. 100-110

Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
Jan/Feb 2008
Pg. 38-47

View Sample
Return to Top